Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Donna C. Porter"'
Autor:
Derek C. Johnson, Michael S. Saag, Sonia Napravnik, Donna C. Porter, Erin Reid, Joseph J. Eron, Jill Palchinsky, William C. Mathews, Sadeep Shrestha
Publikováno v:
AIDS Research and Human Retroviruses. 29:887-891
The Centers for Disease Control (CDC) testing recommendations suggest universal opt-out testing in all health care settings, including cancer clinics. The incidence of non-AIDS-defining cancers (NADCs) is on the rise among HIV patients. However, to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b590dba42e20b0cc6be0b4f4a6791e8
https://doi.org/10.1089/aid.2012.0344
https://doi.org/10.1089/aid.2012.0344
Autor:
Miroslav J. Novak, Donna C. Porter, Patricia N. Fultz, Jackie Stallworth, Marie J. Anderson, Casey D. Morrow
Publikováno v:
Virology. 315:425-437
In the search for an effective vaccine against the human immunodeficiency virus (HIV), novel ways to deliver viral antigens are being evaluated. One such approach is the use of nonreplicating viral vectors encoding HIV and/or SIV genes that are expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531facb3338f9aba2f75e6e9b3c2c6d6
https://doi.org/10.1016/s0042-6822(03)00546-4
https://doi.org/10.1016/s0042-6822(03)00546-4
Autor:
Stephen R. Cole, Daniel R. Drozd, Donna C. Porter, Richard Haubrich, Michael S. Saag, Mari M. Kitahata, Stephen L. Boswell, Lisa Rosenblatt, William Chris Mathews, Andrew O. Westfall, Timothy Juday
Publikováno v:
Medicine
Supplemental Digital Content is available in the text
We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in
We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a372f7d62d4b29223f1de361ec9a8f4a
https://doi.org/10.1097/md.0000000000006275
https://doi.org/10.1097/md.0000000000006275
Publikováno v:
Vaccine. 15:257-264
In this study, we describe the construction of poliovirus genomes or "replicons" which contain the C fragment gene of tetanus toxin substituted for the poliovirus P1 capsid. Upon transfection of replicon RNA into cells, we immunoprecipitated a protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::046a6d121869703ce84ae498e19e1599
https://doi.org/10.1016/s0264-410x(96)00187-9
https://doi.org/10.1016/s0264-410x(96)00187-9
Autor:
Sylvia A. McPherson, Donna C. Porter, Thomas M. Fletcher, Casey D. Morrow, Zina Moldoveanu, Marie J. Anderson
Publikováno v:
AIDS Research and Human Retroviruses. 13:53-62
The effectiveness of the poliovirus vaccines to induce both systemic and mucosal immunity has prompted the development of this virus as a vector in which to express foreign proteins. Our laboratory has previously reported on the construction and char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f517c879d20f46ceb347f42a89ced0ee
https://doi.org/10.1089/aid.1997.13.53
https://doi.org/10.1089/aid.1997.13.53
Publikováno v:
Virology. 219:140-149
Poliovirus genomes encoding the complete gag or env surface gene of the simian immunodeficiency virus SIV smm PBj14 (SIV-PBj14) were constructed. The in vitro -transcribed RNA from these genomes, referred to as replicons, have the capacity for self-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfff6e6f8db5e42af34e853b9dd2280
https://doi.org/10.1006/viro.1996.0231
https://doi.org/10.1006/viro.1996.0231
Publikováno v:
Journal of Virology. 69:1548-1555
Poliovirus genomes which contain small regions of the human immunodeficiency virus type 1 (HIV-1) gag, pol, and env genes substituted in frame for the P1 capsid region replicate and express HIV-1 proteins as fusion proteins with the P1 capsid precurs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f1fc8f0885a833b9cae09ebbeffbbc6
https://doi.org/10.1128/jvi.69.3.1548-1555.1995
https://doi.org/10.1128/jvi.69.3.1548-1555.1995
Publikováno v:
Journal of Virology. 66:4556-4563
The poliovirus capsid precursor polyprotein, P1, is cotranslationally modified by the addition of myristic acid. We have examined the importance of myristylation of the P1 capsid precursor during the poliovirus assembly process by using a recently de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a2a96a9897f0d2a0badf8e308dc01f
https://doi.org/10.1128/jvi.66.7.4556-4563.1992
https://doi.org/10.1128/jvi.66.7.4556-4563.1992
Poliovirus is a member of the Picornaviridae family of viruses. Characteristic of all members of this family, the poliovirus genome consrsis of approx 7500 bp of RNA of the plus sense polarity (1,2). Poliovirus is undoubtedly one of the most thorough
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66fc4c79939dc48f9816259ba39005bb
https://doi.org/10.1385/0-89603-484-4:103
https://doi.org/10.1385/0-89603-484-4:103
Autor:
David D. Ansardi, Donna C. Porter, Casey D. Morrow, Mathew Palmer, Cheryl A. Jackson, Jean D. Peduzzi, Charles N. Cobbs, Andrea W. Bledsoe, Lisa K. Johansen
Publikováno v:
Vector Targeting for Therapeutic Gene Delivery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e21a5bd9781d71d2633ffca34202397b
https://doi.org/10.1002/0471234303.ch16
https://doi.org/10.1002/0471234303.ch16